References
- Collins R, Langman MJS. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 1985; 313: 660–6
- Laine L. Rolling review: upper gastrointestinal bleeding. Aliment Pharmacol Ther 1993; 7: 207–32
- Gray BN, De Zwart J, Andrewarthur L, Crowley S, Kamm M, Watson K. Controlled clinical trial of ranitidine in bleeding peptic ulcer. Aust NZ J Surg 1986; 56: 723–7
- Walt RP, Cottrell J, Mann SG, Freemantle NP, Langman MJS. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1992; 340: 1058–62
- Green FW, Marshall MK, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978; 74: 38–43
- Merki HS, Witzel L, Kaufman D, Kempf M, Neumann J, Röhmel J. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer. Gut 1988; 29: 453–7
- Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing. Gastroenterology 1994; 106: 60–4
- Kiilerich S, Rannem T, Elsborg L. Effect of intravenous omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995; 56: 25–30
- Nielsen J, Ström M, Fernström P. Effect of continuous infusion of omeprazole and ranitidine on intragastric acidity. Scand J Gastroenterol 1990; 25: 95, Suppl 176
- Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial. Digestion 1990; 45: 217–25
- Daneshmend TK, Hawkey CJ, Langman MJS, Logan RFA, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomized double blind controlled trial. Br Med J 1992; 304: 143–7
- Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a metaanalysis. Gastroenterology 1992; 102: 139–48
- Kohler B, Benz C, Maier M, Knobloch M, Riemann JF. Gastric pH-monitoring in patients with acute ulcer bleeding under continuous intravenous therapy with omeprazole (om) or ranitidine (ran). Gastroenterology 1994; 106: A 109
- Labenz J, Leusing C, Sollböhmer M, Tillenburg B, Börsch G. Gastric pH profiles in patients with peptic ulcer bleeding treated with continuous infusions of omeprazole or ranitidine. Gastroenterology 1994; 106: A 114
- Mones J, Sainz S, Balanzó J, Torras X, Novella MT, Villanueva C. 24-hour intragastric pH-metry in patients with a bleeding duodenal ulcer with a visible vessel. Comparison of intravenous (i.v.) omeprazole vs. i.v. ranitidine. Gastroenterology 1994; 106: A 142
- Fullarton GM, MacDonald AM, Mann SG, McColl KEL. Controlled study of the effects of intravenous famotidine on intragastric pH in bleeding peptic ulcers. Aliment Pharmacol Ther 1991; 5: 77–84
- Mueller X, Rothenbuehler J-M, Amery A, Harder F. Factors predisposing to further hemorrhage and mortality after peptic ulcer bleeding. J Am Coll Surg 1994; 179: 457–61
- Choudari CP, Elton RA, Palmer KR. The outcome of peptic ulcer haemorrhage in relation to consumption of nonsteroidal anti-inflammatory drugs and aspirin. Aliment Pharmacol Ther 1994; 8: 457–60
- Christiansen J, Ottenjann R, Arx F. Placebo-controlled trial with the somatostatin analogue SMS 201–995 in peptic ulcer bleeding. Gastroenterology 1989; 97: 568–74
- Silverstein FE, Gilbert DA, Tedesco FJ, Buenger JK, Persing J. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 1981; 27: 80–93
- Laine L, Freeman M, Cohen H. Lack of uniformity in evaluation of endoscopic prognostic features of bleeding ulcers. Gastrointest Endosc 1994; 40: 411–17